ARTICLE | Company News
Invitrogen, Zymed Laboratories Inc. deal
January 17, 2005 8:00 AM UTC
Research tool and reagent provider IVGN will acquire antibody manufacturer Zymed for $60 million in cash. The purchase price is four times the $15 million in sales that IVGN expects from Zymed in the ...